Reports Q4 revenue $$227.00M, consensus $140.95M.”With the recent launch of our first independent medicine, TRYNGOLZA for familial ...

Every morning, eight-year-old Isabelle watches from the window as her two sisters Madison and Olivia leave to walk to school. “Izzy gets so excited, because she thinks she’s going to go. But then, she ...

Neuren Pharmaceuticals (ASX: NEU) has announced that the US Food and Drug Administration (FDA) has granted Fast Track ...